Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Teladoc Health, Inc. (TDOC) had Revenue of $2.57B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.57B
Net Income	$-1.00B
Cost of Goods Sold	$751.27M
Gross Profit	$1.82B
Operating Expenses	$3.59B
Operating Income	$-1.02B
Non-Operating Income/Expense	$27.23M
Pre-Tax Income	$-993.65M
Normalized Pre-Tax Income	$-993.65M
Income after Taxes	$-1.00B
Income from Continuous Operations	$-1.00B
Consolidated Net Income/Loss	$-1.00B
Normalized Income after Taxes	$-1.00B
EBIT	$-1.02B
EBITDA	$151.96M
Weighted-Average Shares Outstanding (Basic)	170.56M
Weighted-Average Shares Outstanding (Diluted)	170.56M
Earnings per Share (EPS) (Basic)	$-5.87
Earnings per Share (EPS) (Diluted)	$-5.87
Balance Sheet Financials
Current Assets	$1.66B
Property, Plant, and Equipment	$29.49M
Long-Term Assets	$1.85B
Total Assets	$3.52B
Current Liabilities	$941.53M
Long-Term Debt	$991.42M
Long-Term Liabilities	$1.08B
Total Liabilities	$2.03B
Common Equity	$1.49B
Tangible Shareholders Equity	$-223.47M
Shareholders Equity	$1.49B
Common Shares Outstanding	173.41M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$293.68M
Cash Flow from Investing Activities	$-124.05M
Cash Flow from Financial Activities	$8.31M
Beginning Cash	$1.12B
End Cash	$1.30B
Increase/Decrease in Cash	$174.65M
Stock-Based Compensation	$145.95M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.77
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	1.03
Gross Margin	70.76%
Operating Margin	-39.73%
EBIT Margin	-39.73%
EBITDA Margin	5.91%
Pre-Tax Profit Margin	-38.67%
Profit Margin	-38.97%
Free Cash Flow	$169.63M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.73
Inventory Turnover	19.70
Receiveable Turnover	12.00
Days Sales in Receivables	30.42
Return on Equity	-67.15%
Return on Tangible Equity	448.04%
Return on Assets	-28.47%
Return on Investments	-40.33%
Book Value Per Share	$8.60
Free Cash Flow per Share	$0.99
Operating Cash Flow per Share	$1.72

Data from Zacks Investment Research, Inc.